journal article·2019-10-09

Transformation of Viral Light Particles into Near-Infrared Fluorescence Quantum Dot-Labeled Active Tumor-Targeting Nanovectors for Drug Delivery

Cheng Lv, Tian-Yu Zhang, Yi Lin, Man Tang, Cai-Hua Zhai, Hou-Fu Xia, Ji Wang, Zhi-Ling Zhang, Zhi-Xiong Xie, Gang Chen, Dai-Wen Pang

Nano Letters· Volume 19· Issue 10
Publisher page

Abstract

Nanosized oncolytic viral light particles (L-particles), separated from progeny virions, are composed of envelopes and several tegument proteins of viruses, free of nucleocapsids. The noninfectious L-particles experience the same internalization process as mature oncolytic virions, which exhibits great potential to act as targeted therapeutic platforms. However, the clinical applications of L-particle-based theranostic platforms are rare due to the lack of effective methods to transform L-particles into nanovectors. Herein, a convenient and mild strategy has been developed to transform L-particles into near-infrared (NIR) fluorescence Ag2Se quantum dot (QD)-labeled active tumor-targeting nanovectors for real-time in situ imaging and drug delivery. Utilizing the electroporation technique, L-particles can be labeled with ultrasmall water-dispersible NIR fluorescence Ag2Se QDs with a labeling efficiency of ca. 85% and loaded with antitumor drug with a loading efficiency of ca. 87%. Meanwhile, by harnessing the infection mechanism of viruses, viral L-particles are able to recognize and enter tumor cells without further modification. In sum, a trackable and actively tumor-targeted theranostics nanovector can be obtained efficiently and simultaneously. Such multifunctional nanovectors transformed from viral L-particles have exhibited excellent properties of active tumor-targeting, in vivo tumor imaging, and antitumor efficacy, which opens a new window for the development of natural therapeutic nanoplatforms.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Virus-based gene therapy research · RNA Interference and Gene Delivery · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences, State Key Laboratory of Virology, The Institute for Advanced Studies, and Wuhan Institute of Biotechnology, Wuhan University, Wuhan 430072, People’s Republic of China

College of Life Sciences, Wuhan University, Wuhan 430072, People’s Republic of China

Key Laboratory of Oral Biomedicine (Ministry of Education) and Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, Wuhan 430072, People’s Republic of China

State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Sciences, and College of Chemistry, Nankai University, Tianjin 300071, People’s Republic of China

Funding

National Natural Science Foundation of China

References (38)

Show source-provided references
1. Knipe, D. M.; Howley, P. M.; Griffin, D. E. Fields virology; Lippincott Williams & Wilkins, 2001; pp 60–98.
2. 10.1038/nrd259110.1038/nrd2591 ↗
3. 10.1002/adma.20160556310.1002/adma.201605563 ↗
4. 10.1002/adma.20130459210.1002/adma.201304592 ↗
5. 10.1002/adma.20130273710.1002/adma.201302737 ↗
6. 10.1038/nrmicro161510.1038/nrmicro1615 ↗
7. 10.1016/j.cell.2006.02.01810.1016/j.cell.2006.02.018 ↗
8. 10.2217/fvl.15.8510.2217/fvl.15.85 ↗
9. 10.1128/MMBR.69.3.462-500.200510.1128/MMBR.69.3.462-500.2005 ↗
10. 10.1128/JVI.77.9.5324-5332.200310.1128/JVI.77.9.5324-5332.2003 ↗
11. 10.1128/JVI.03631-1310.1128/JVI.03631-13 ↗
12. 10.1128/JVI.79.11.6655-6663.200510.1128/JVI.79.11.6655-6663.2005 ↗
13. 10.1038/nrc94810.1038/nrc948 ↗
14. 10.1038/sj.cgt.770053710.1038/sj.cgt.7700537 ↗
15. 10.1038/nbt.228710.1038/nbt.2287 ↗
16. 10.1099/0022-1317-72-3-66110.1099/0022-1317-72-3-661 ↗
17. 10.1128/mBio.00820-1610.1128/mBio.00820-16 ↗
18. 10.1128/mBio.00063-1210.1128/mBio.00063-12 ↗
19. 10.1006/viro.1997.889310.1006/viro.1997.8893 ↗
20. 10.1586/14760584.1.4.42710.1586/14760584.1.4.427 ↗
21. 10.1016/0042-6822(92)90906-610.1016/0042-6822(92)90906-6 ↗
22. 10.1146/annurev-micro-092611-15005110.1146/annurev-micro-092611-150051 ↗
23. 10.1111/cmi.1209310.1111/cmi.12093 ↗
24. 10.1021/acs.molpharmaceut.7b0015810.1021/acs.molpharmaceut.7b00158 ↗
25. 10.1021/ja208955310.1021/ja2089553 ↗
26. 10.1021/jacs.5b1034010.1021/jacs.5b10340 ↗
27. 10.1021/ac301835f10.1021/ac301835f ↗
28. 10.1016/S0006-3495(91)82054-910.1016/S0006-3495(91)82054-9 ↗
29. 10.1021/acsnano.6b0563010.1021/acsnano.6b05630 ↗
30. 10.1021/acsami.6b1463310.1021/acsami.6b14633 ↗
31. 10.1111/j.2042-7158.2012.01567.x10.1111/j.2042-7158.2012.01567.x ↗
32. 10.1111/j.1365-2818.1993.tb03313.x10.1111/j.1365-2818.1993.tb03313.x ↗
33. 10.1523/JNEUROSCI.0346-04.200410.1523/JNEUROSCI.0346-04.2004 ↗
34. 10.1111/j.1365-2818.2006.01706.x10.1111/j.1365-2818.2006.01706.x ↗
35. 10.1128/JVI.78.14.7508-7517.200410.1128/JVI.78.14.7508-7517.2004 ↗
36. 10.1128/JVI.79.12.7609-7616.200510.1128/JVI.79.12.7609-7616.2005 ↗
37. 10.1016/j.coviro.2011.12.00110.1016/j.coviro.2011.12.001 ↗
38. 10.1039/C8CC05614E10.1039/C8CC05614E ↗